Tirzepatide improved markers of islet cell function and insulin sensitivity compared to semaglutide in people with type 2 diabetes

Category Primary study
ConferenceDiabetologia
Year 2022
This article has no abstract
Epistemonikos ID: 884f41488e33c3a83a157ec8a08956db6012da75
First added on: Apr 30, 2026